Cardiovascular Systems (NSDQ:CSII) this week posted third-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. The St. Paul, Minnesota-based heart device company reported losses of $9.7 million, or -25¢ per share, on sales of $56.2 million for the three months ended March 31, for a sales loss of -11.15% compared […]
Cardiovascular Systems
Cardiovascular Systems treats first patients using Propel pVAD
Cardiovascular Systems (Nasdaq:CSII) today announced the first in-human procedures using its Propel percutaneous ventricular assist device. The first patients were treated at Piedmont Heart Institute and Cardiovascular Services in Tbilisi, Georgia by Dr. David Kandzari. The St. Paul, Minnesota-based company reported that Propel performed as intended and provided uninterrupted hemodynamic support leading to successful revascularization. […]
Former Cardiovascular Systems chief medical officer joins Big Sky Biomedical incubator
Dr. Ryan Egeland — who served as Cardiovascular Systems’ chief medical officer until earlier this month — has joined the Big Sky Biomedical incubator as a managing director. “Big Sky Biomedical was founded to enhance early-stage innovation and development in some of the fastest-growing segments of healthcare, including neurovascular, structural heart, and regenerative medicine,” Egeland […]
Cardiovascular Systems appoints chief medical officer
Cardiovascular Systems (NSDQ:CSII) announced today that it appointed Dr. Jeffery W. Chambers as its chief medical officer. St. Paul, Minnesota-based Cardiovascular Systems said in a news release that Chambers served as the primary investigator for the Orbit II study — the pivotal trial supporting premarket approval for the use of orbital atherectomy in coronary arteries. […]
Cardiovascular Systems, Innova Vascular partner to develop thrombectomy devices
Cardiovascular Systems (NSDQ:CSII) this week announced that it has partnered with Innova Vascular to develop a full line of thrombectomy devices. Under the terms of the agreement, Cardiovascular Systems will provide financing to Innova to develop thrombectomy devices to remove blood clots from arteries and veins. Cardiovascular Systems will have exclusive rights to acquire the devices […]
Cardiovascular Systems cites lower procedure volumes due to COVID-19 variants for missed Q2 estimates
Cardiovascular Systems (NSDQ:CSII) posted second-quarter results this week that missed the overall consensus on Wall Street, citing issues caused by COVID-19 variants. The St. Paul, Minnesota-based company reported losses of $8.97 million, or -23¢ per share, on sales of $59.14 million for the three months ended Dec. 31, 2021, on sales loss of -7.84% compared […]
The top 10 catheter innovations of 2021
Last year was a big year for catheter innovation as medtech companies large and small received regulatory approvals for devices ranging from TAVR to single-use endoscopes. Catheter innovations weren’t limited to just adults; Catheter-deployed devices for premature babies and toddlers were also approved and released. And catheter-based devices made up nearly half of last year’s Prix […]
Cardiovascular Systems’ recall of its Wirion embolic protection device is Class I
The FDA determined that Cardiovascular Systems’ recall of some of its Wirion embolic protection devices is Class I, the most serious kind. St. Paul, Minnesota–based Cardiovascular Systems is recalling all products and lots of its Wirion embolic protection device due to complaints of filter breakage during retrieval. It includes devices with manufacturing dates of Jan. […]
How medtech fared in the first waves of the pandemic
Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial […]
Cardiovascular Systems sales up 66% in Q4
Cardiovascular Systems (NSDQ:CSII) posted fourth-quarter results that beat the overall consensus on Wall Street. The St. Paul, Minn.-based company yesterday evneing reported losses of –$5.3 million, or -14¢ per share, on sales of $70.7 million for the three months ended June 30, 2021 — versus a loss of –$15.2 million on sales of 42.5 million […]
Cardiovascular Systems launches peripheral balloon catheter
Cardiovascular Systems (NSDQ:CSII) today said it has launched its OrbusNeich Jade percutaneous transluminal angioplasty over-the-wire balloon catheter in the U.S. Jade is an over-the-wire (OTW) balloon catheter for the peripheral vasculature, including obstructed native arteries and synthetic arteriovenous dialysis fistulae and post-dilation of balloon-expandable and self-expanding stents. Get the full story on our sister site, Medical […]
